Literature DB >> 91159

alpha 1-Fetoprotein mRNA of rat yolk sac and hepatoma.

J F Chiu, W Decha-Umphai, P Commer.   

Abstract

Rat alpha 1-fetoprotein mRNA was isolated and purified to apparent homogeneity by means of immunoadsorption and oligo (dT) cellulose affinity chromatography. Purified AFP mRNA migrated as a 21S peak in 2.5% SDS-polyacrylamide gels. The translation product of this mRNA in micrococcal nuclease treated reticulocyte lysate was identified as AFP by specific immunoprecipitation, SDS-gel electrophoresis and tryptic digestion analysis. DNA complimentary to AFP mRNA was synthesized with avian meyloblastosis virus RNA-dependent DNA polymerase. This AFP cDNA was used as a probe to quantitate AFP mRNA in the developing rat liver and to compare the complexity and diversity of AFP mRNA derived from the normal rat liver and Morris hepatoma 7777. We found that the amount of functional AFP mRNA is decreasing during liver development. There is very little, if any, AFP mRNA in the adult rat liver. A high degree of homology between the AFP mRNA sequences of yolk sac and hepatoma was also found.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 91159      PMCID: PMC328009          DOI: 10.1093/nar/7.1.239

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  27 in total

1.  Production of embryonal alpha-globulin by transplantable mouse hepatomas.

Authors:  G I ABELEV; S D PEROVA; N I KHRAMKOVA; Z A POSTNIKOVA; I S IRLIN
Journal:  Transplantation       Date:  1963-04       Impact factor: 4.939

2.  Immunochemical isolation and characterization of ovalbumin messenger ribonucleic acid.

Authors:  D J Shapiro; R T Schimke
Journal:  J Biol Chem       Date:  1975-03-10       Impact factor: 5.157

3.  Regulation of in vitro mRNA transcription by a fraction of chromosomal proteins.

Authors:  J F Chiu; Y H Tsai; K Sakuma; L S Hnilica
Journal:  J Biol Chem       Date:  1975-12-25       Impact factor: 5.157

4.  Normal and increased alpha-fetoprotein in neoplastic and non-neoplastic liver disease.

Authors:  E Ruoslahti; M Seppälä
Journal:  Lancet       Date:  1972-08-05       Impact factor: 79.321

5.  Sites of alpha-fetoprotein synthesis.

Authors:  D Gitlin
Journal:  N Engl J Med       Date:  1971-12-16       Impact factor: 91.245

6.  Isolation of rat liver albumin messenger RNA.

Authors:  J M Taylor; T P Tse
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

7.  Serum alpha-feto-protein. VII. The range of apparent serum values in normal people, pregnant women, and primary liver cancer high risk populations.

Authors:  L R Purves; W R Branch; E W Geddes; C Manso; M Portugal
Journal:  Cancer       Date:  1973-03       Impact factor: 6.860

8.  Immunoadsorption of specific chicken oviduct polysomes. Isolation of ovalbumin, ovomucoid, and lysozyme messenger RNA.

Authors:  B Groner; N E Hynes; A E Sippel; S Jeep; M Chi-Nguyen-Huu; G Schütz
Journal:  J Biol Chem       Date:  1977-10-10       Impact factor: 5.157

9.  Isolation and characterization of a human fetal-alpha-globulin from the sera of fetuses and a hepatoma patient.

Authors:  S Nishi
Journal:  Cancer Res       Date:  1970-10       Impact factor: 12.701

10.  Studies of carcino-fetal proteins. II. Biochemical comparison of -fetoprotein from human fetuses and patients with hepatocellular cancer.

Authors:  E Ruoslahti; M Seppälä; H Pihko; P Vuopio
Journal:  Int J Cancer       Date:  1971-09-15       Impact factor: 7.396

View more
  2 in total

1.  Hormonal modulation of alpha-fetoprotein gene expression in newborn rat livers.

Authors:  J F Chiu; R J Massari; C E Schwartz; N T Meisler; J W Thanassi
Journal:  Nucleic Acids Res       Date:  1981-12-21       Impact factor: 16.971

2.  Administration of 3-methylcholanthrene to rats increases the specific hybridizable mRNA coding for cytochrome P-450c.

Authors:  E Bresnick; M Brosseau; W Levin; L Reik; D E Ryan; P E Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.